The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.

Eye on the Cure Podcast | Episode 97: Lindsey Rambo

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.